Rule-based modeling of blood transcriptome reveals combinatorial markers of RhCMV/SIV vaccine protection
Year: 2026
Type: article
Abstract: Using whole blood RNA-seq data from RhCMV/SIV-vaccinated rhesus macaques subsequently challenged with SIV, we identified 70 immune genes that distinguish protection status in these animals against persistent SIV infection. The application of a non-linear rule-based model allowed us to refine the whole blood protective signature into gene combinations and their specific expression levels related to cell death and inflammatory signaling pathways. The co-predictiveness exhibited by the model indicated that protected animals display an orchestrated immune response, whereas vaccine programming of these processes were absent in non-protected animals. Upstream regulator analysis revealed high resolution into IL-15 signaling linked with IL-23 and JNK1 enabled by the interpretable nature of the rule-based model.
Source: iScience
Authors: Girish Pulinkala(Methodology, Writing – original draft, Writing – review & editing), Kaitlin Sawatzki(Methodology), Elise Smith(Investigation), Jean Chang(Investigation), Inah Golez(Investigation), Scott G. Hansen(Resources), Jennifer Tisoncik-Go(Supervision, Writing – review & editing), Louis J. Picker(Conceptualization, Resources), Michael Gale(Conceptualization, Funding acquisition, Investigation), Jan Komorowski(Conceptualization, Methodology, Writing – original draft, Writing – review & editing)
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,240
Funders: Foundation for the National Institutes of Health, U.S. Department of Health and Human Services, Bill and Melinda Gates Foundation, VINNOVA, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Awards: G2953680498, G3142915748, G6357575410, University of Minnesota - to develop a prophylactic vaccine against HIV that is practical for utilization in low- and middle-income countries to reach those individuals most..., Mechanisms programming Protective Immunity from RhCMV-SIV Vaccine and IL-15 actions, Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
OpenAlex ID: W7170864375
